CCL2 and cystic fibrosis: In addition, AZM significantly reduces the expression of the proinflammatory cytokine IL-1β and the chemokine C-C motif ligand (CCL)-2 and TNF-α in M1-induced cystic fibrosis alveolar macrophages in patients with cystic fibrosis [17].